These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11694011)

  • 21. Some factors associated with the ultrasonic nebulization of proteins.
    Niven RW; Ip AY; Mittelman S; Prestrelski SJ; Arakawa T
    Pharm Res; 1995 Jan; 12(1):53-9. PubMed ID: 7724488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
    Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
    Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers.
    McCallion ON; Taylor KM; Thomas M; Taylor AJ
    Pharm Res; 1995 Nov; 12(11):1682-8. PubMed ID: 8592670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective nebulization of interferon-γ using a novel vibrating mesh.
    Sweeney L; McCloskey AP; Higgins G; Ramsey JM; Cryan SA; MacLoughlin R
    Respir Res; 2019 Apr; 20(1):66. PubMed ID: 30943978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing the in vitro deposition of tobramycin aerosol: a comparison of an ultrasonic nebulizer and a high-frequency vibrating mesh nebulizer.
    Pedersen KM; Handlos VN; Heslet L; Kristensen HG
    J Aerosol Med; 2006; 19(2):175-83. PubMed ID: 16796542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface active drugs significantly alter the drug output rate from medical nebulizers.
    Arzhavitina A; Steckel H
    Int J Pharm; 2010 Jan; 384(1-2):128-36. PubMed ID: 19825407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro deposition properties of nebulized formoterol fumarate: effect of nebulization time, airflow, volume of fill and nebulizer type.
    Okapo SO; Gupta J; Martinez E; Mark R
    Curr Med Res Opin; 2009 Apr; 25(4):807-16. PubMed ID: 19207092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Droplets merging through wireless ultrasonic actuation.
    Nayak PP; Kar DP; Bhuyan S
    Ultrasonics; 2016 Jan; 64():83-8. PubMed ID: 26299402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Benefits of nebulized therapy: basic concepts].
    Máiz Carro L; Wagner Struwing C
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():2-7. PubMed ID: 21703472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of nebulized buparvaquone nanosuspensions--effect of nebulization technology.
    Hernández-Trejo N; Kayser O; Steckel H; Müller RH
    J Drug Target; 2005; 13(8-9):499-507. PubMed ID: 16332575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. That's cool!--Nebulization of thermolabile proteins with a cooled vibrating mesh nebulizer.
    Hertel S; Pohl T; Friess W; Winter G
    Eur J Pharm Biopharm; 2014 Jul; 87(2):357-65. PubMed ID: 24662437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of ultrasonic nebulized aerosols to a lung model during mechanical ventilation.
    Thomas SH; O'Doherty MJ; Page CJ; Treacher DF; Nunan TO
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):872-7. PubMed ID: 8214941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of recombinant consensus interferon to air-jet and ultrasonic nebulization.
    Ip AY; Arakawa T; Silvers H; Ransone CM; Niven RW
    J Pharm Sci; 1995 Oct; 84(10):1210-4. PubMed ID: 8801336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of fluid physicochemical properties on vibrating-mesh nebulization.
    Ghazanfari T; Elhissi AM; Ding Z; Taylor KM
    Int J Pharm; 2007 Jul; 339(1-2):103-11. PubMed ID: 17451896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applicability of an ultrasonic nebulization system for the airways delivery of beclomethasone dipropionate in a murine model of asthma.
    Hrvacić B; Bosnjak B; Tudja M; Mesić M; Merćep M
    Pharm Res; 2006 Aug; 23(8):1765-75. PubMed ID: 16832613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of particle and mass distribution of pentamidine aerosol by ultrasonic and air jet nebulizers.
    Hager J; Gober KH; Löhr JP; Dürr M
    J Aerosol Med; 1992; 5(2):65-79. PubMed ID: 10147685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro characteristics of tobramycin aerosol from ultrasonic and jet nebulizers.
    Asmus MJ; Milavetz G; Tice AL; Teresi ME
    Pharmacotherapy; 2001 May; 21(5):534-9. PubMed ID: 11349742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of nebulizer type with different pediatric aerosol masks on drug deposition in a model of a spontaneously breathing small child.
    Lin HL; Wan GH; Chen YH; Fink JB; Liu WQ; Liu KY
    Respir Care; 2012 Nov; 57(11):1894-900. PubMed ID: 22418694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features.
    Dailey LA; Schmehl T; Gessler T; Wittmar M; Grimminger F; Seeger W; Kissel T
    J Control Release; 2003 Jan; 86(1):131-44. PubMed ID: 12490379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.